Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Menopause-related skin changes may increase fungal infections and inflammation.

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Spironolactone most effective for hirsutism, but has side effects.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The research improved understanding of twin births and fertility in Tibetan sheep, helping animal farming.